MedPath

The effect of cilnidipine on sympathetic nerve activity and glycemic control in type 2 diabetic patients

Not Applicable
Conditions
Type 2 diabetes mellitus Hypertension
Registration Number
JPRN-UMIN000004926
Lead Sponsor
Department of Internal Medicine, School of Medicine, Keio University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1. Malignant hypertension 2. (possible) pregnant women 3. Severe liver dysfunction 4. History of severe side effects to calcium channel blockers 5. Patients who was considered to be difficult to take part in this trial by physician in charge

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
serum catecholamine concentration value of HbA1c
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath